Near-haploid acute lymphoblastic leukemia is rare subgroup of the disease, which is very important due to very poor prognosis and resistance to treatment including novel monoclonal antibodies and CAR-T therapy.

Center of Molecular Biology and Genetics Department of Internal Medicine Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia

Central European Institute of Technology Masaryk University Brno Czechia

Department of Clinical Hematology University Hospital Brno Czechia

Department of Internal Medicine Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia

Department of Medical Genetics and Genomics University Hospital and Faculty of Medicine Brno Czechia

Zobrazit více v PubMed

Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci. 2008;121:1‐84. PubMed

Ben‐David U, Amon A. Context is everything: aneuploidy in cancer. Nat Rev Genet. 2020;21:44‐62. PubMed

Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet. 2012;13:189‐203. PubMed

Duijf PGH, Schultz N, Benezra R. Cancer cells preferentially lose small chromosomes. Int J Cancer. 2013;132:2316‐2326. PubMed PMC

Safavi S, Paulsson K. Near‐haploid and low‐hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis. Blood. 2017;129(4):420‐423. PubMed

Lundin‐Ström KL, Ström K, Biloglav A, et al. Parental origin of monosomic chromosomes in near‐haploid acute lymphoblastic leukemia. Blood Cancer J. 2020;10:51. PubMed PMC

Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed February 22, 2021.

Callen DF, Raphael K, Michael PM, Garson OM. Acute lymphoblastic leukemia with a hypodiploid karyotype with less than 40 chromosomes: the basis for division into two subgroups. Leukemia. 1989;3(10):749‐752. PubMed

Gibbons B, MacCallum P, Watts E, et al. Nearhaploid acute lymphoblastic leukemia: seven new cases and a review of the literature. Leukemia. 1991;5(9):738‐743. PubMed

Oshimura M, Freeman AI, Sandberg AA. Chromosomes and causation of human cancer and leukemia. XXIII. Near‐haploidy in acute leukemia. Cancer. 1977;40(3):1143‐1148. PubMed

Ma SK, Chan GCF, Wan TSK, et al. Near‐haploid common acute lymphoblastic leukaemia of childhood with a second hyperdiploid line: a DNA ploidy and fluorescence in‐situ hybridization study. Br J Haematol. 1998;103(3):750‐755. PubMed

Misawa S, Oguma N, Testa JR. A case of acute lymphoblastic leukemia with severe hypodiploidy. Cancer Genet Cytogenet. 1985;16(2):137‐143. PubMed

Moorman A. The clinical relevance of chromosomal and genomic abnormalities in B‐cell precursor acute lymphoblastic leukaemia. Blood Rev. 2012;26:123‐135. PubMed

Navrkalova V, Plevova K, Hynst J, et al. LYNX (LYmphoid NeXt‐generation sequencing) panel: a comprehensive capture‐based sequencing tool for the analysis of prognostic and predictive markers in lymphoid malignancies. J Mol Diagnostics. 2021;23(8):959‐974. PubMed

Zhang W, Kuang P, Liu T. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta‐analysis. Ann Med. 2019;51(1):28‐40. PubMed PMC

Zhang W, Kuang P, Li H, Wang F, Wang Y. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta‐analysis. Ann Hematol. 2017;96(2):215‐225. PubMed

Stanulla M, Dagdan E, Zaliova M, et al. IKZF1plus defines a new minimal residual disease‐dependent very‐poor prognostic profile in pediatric B‐cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36(12):1240‐1249. PubMed

Zaliova M, Stuchly J, Winkowska L, et al. Genomic landscape of pediatric B‐other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 2019;104(7):1396‐1406. PubMed PMC

da Conceição BT, Mansur MB, Blunck CB, Emerenciano M, Pombo‐de‐Oliveira MS. Characterization of RB1 in pediatric TCF3‐PBX1+ acute lymphoblastic leukemia. Blood. 2017;130(Supplement 1):3976.

Hrabovsky S, Vrzalova Z, Stika J, et al. Genomic landscape of B‐other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR‐ABL1‐like subtype. Acta Oncol. 2021;22:1‐11. PubMed

Laycock‐van Spyk S, Thomas N, Cooper DN, Upadhyaya M. Neurofibromatosis type 1‐associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genomics. 2011;5(6):623‐690. doi:10.1186/1479-7364-5-6-623 PubMed DOI PMC

Roberts KG, Li Y, Payne‐Turner D, et al. Targetable kinase‐activating lesions in Ph‐like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005‐1015. PubMed PMC

Pui HC, Rebora P, Schrappe M, et al. Outcome of children with hypodiploid acute lymphoblastic leukemia: a retrospective multinational study. J Clin Oncol. 2019;37(10):770‐780. PubMed PMC

Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B‐cell lymphoblastic leukemia. N Engl J Med. 2018;378:439‐448. PubMed PMC

Gökbuget N, Dombret H, Bonifacio M, et al. Blinatumomab for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukemia. Blood. 2018;131:1522‐1531. PubMed PMC

Frismantas V, Dobay MP, et al. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug‐resistant acute lymphoblastic leukemia. Blood. 2017;129(11):e26‐e37. PubMed PMC